MTEM
Molecular Templates Inc

2,089
Mkt Cap
$658.00
Volume
2,047.00
52W High
$1.59
52W Low
$0.00
PE Ratio
0.00
MTEM Fundamentals
Price
$0.0001
Prev Close
$0.0001
Open
$0.0001
50D MA
$0.0007
Beta
0.00
Avg. Volume
3,447.75
P/B
0.00
Loading...
Loading...
News
all
press releases
Bristol Myers ends collaboration agreement with Molecular Templates
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
More News
News Placeholder
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
AUSTIN, Texas, March 29, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates, or MTEM ), a clinical-stage biopharmaceutical company focused on the discovery and...
Globe Newswire·2y ago
News Placeholder
Molecular Templates reports Q4 EPS (73c), one estimate (97c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
Molecular Templates GAAP EPS of -$0.73, revenue of $7.02M
Molecular Templates GAAP EPS of -$0.73, revenue of $7.02M...
SeekingAlpha.com: All News·2y ago
News Placeholder
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
AUSTIN, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates, or MTEM ), a clinical-stage biopharmaceutical company focused on the discovery and...
Globe Newswire·2y ago
News Placeholder
Molecular Templates, Inc. Provides Interim Update
Monotherapy activity with PD-L1-targeting MT-6402 in Head and Neck Cancer; Unique pharmacodynamic effects with CTLA-4 targeting MT-8421 in on-going phase I study Monotherapy Activity with MT-6402...
Globe Newswire·2y ago
News Placeholder
Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
AUSTIN, Texas, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, Molecular Templates, or MTEM ), a clinical-stage biopharmaceutical company developing novel therapeutics...
Globe Newswire·2y ago

Latest MTEM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.